Search
Maria Jasin, a member of the Sloan Kettering Institute’s Developmental Biology Program, discusses her research.
This year, the GSK student-run Experimental Therapeutics Symposium highlighted MSK’s expertise in successfully moving novel therapies from bench to bedside.
A new lung cancer research center has been created at Memorial Sloan Kettering Cancer Center (MSK). The Fiona and Stanley Druckenmiller Center for Lung Cancer Research (DCLCR) is a multidisciplinary research initiative dedicated to developing innovative and more-effective treatments for people with lung cancer.
Learn how new research and clinical trials at Memorial Sloan Kettering Cancer Center (MSK) have helped 32-year-old Giancarlo Oviedo-Mori survive — and thrive — with advanced lung cancer for 15 years.
Obtenga información sobre cómo la nueva investigación y los ensayos clínicos en el Memorial Sloan Kettering Cancer Center (MSK) han ayudado a Giancarlo Oviedo-Mori, de 32 años, a sobrevivir, y prosperar, con cáncer pulmonar avanzado durante 15 años.
What proportion of cancer patients are eligible to benefit from precision oncology? There is an ongoing debate on this issue, partly due to a lack of consensus on which gene mutations are clinically actionable.
Experts at Memorial Sloan Kettering Cancer Center reviewed the research and found that whole food plant based diets are better than ketogenic diets at reducing cancer risk and helping people after cancer treatment live healthier lives.
Called NEXT, the factor plays an important role in handing over RNA to the exosome for destruction.
It’s rare to meet someone who makes you want to be a better person. Cristy and Alec Fraser are those people — they are inspiring in an extraordinary and life-changing way.
At the ASCO meeting in Chicago, MSK medical oncologist William Tap talked about disappointing results from a new sarcoma drug, which didn’t increase survival.